Form 4: Ulta Beauty CEO David Kimbell Receives Stock and Option Grants
SEC Form 4 Filing
Ulta Beauty's CEO, David C. Kimbell, was granted 3,667 shares of restricted stock and options to purchase 18,239 shares of common stock on March 29, 2024.
Summary
- David C. Kimbell, CEO of Ulta Beauty, received a grant of 3,667 shares of restricted stock on March 29, 2024.
- These shares vest 100% on March 15, 2027.
- Kimbell also received options to purchase 18,239 shares of Ulta Beauty common stock at an exercise price of $522.88.
- These options vest in 25% annual increments starting March 15, 2025, and continuing through March 15, 2028.
- Following these transactions, Kimbell directly owns 45,736 shares of Ulta Beauty common stock and options to purchase 18,239 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The grant of equity compensation is a standard practice and signals confidence in the CEO's ability to drive future growth. However, it's not a major event that would significantly impact the stock price.
Positives
- The grant of restricted stock and stock options to the CEO aligns his interests with those of the shareholders, incentivizing him to drive long-term value creation.
- The vesting schedules for both the stock and options encourage continued service and commitment from the CEO.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Equity compensation is a common practice in the retail industry to incentivize and retain top executives. The size and structure of the grants are likely benchmarked against peer companies in the beauty and personal care sector.
Comparison to Industry Standards
- Equity grants to CEOs in the retail sector are common, with the size and vesting schedules varying based on company performance, tenure, and industry benchmarks.
- Comparable companies like Sephora (LVMH), Estee Lauder, and L'Oreal also utilize stock options and restricted stock units as part of their executive compensation packages.
- The vesting schedule of 25% annually is a fairly standard practice to ensure long-term commitment.
Stakeholder Impact
- Shareholders: The equity grants align the CEO's interests with those of the shareholders, potentially leading to increased shareholder value.
- Employees: The grants can boost employee morale by demonstrating that the company is investing in its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Date of the stock and option grants. |
| 03/15/2027 | Date when the restricted stock vests 100%. |
| 03/15/2025 | First vesting date for the stock options (25%). |
| 03/15/2028 | Final vesting date for the stock options (25%). |
| 04/02/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.